Treatment of U87 and U251 glioblastoma cells with naringin blocked cell proliferation through suppression of the FAK/cyclin D1 pathway and induction of cell apoptosis via the FAK/Bad pathway. The gene discussed is PTK2; the disease is glioblastoma.